Cargando…

Timely Recognition and Early Multi-Step Antinflammatory Therapy May Prevent ICU Admission of Patients With MIS-C: Proposal for a Severity Score

In this observational study, we report the clinical, therapeutics and outcome features of 23 patients with multisystem inflammatory syndrome (MIS-C) who have been treated in Gaslini Children Hospital (Genoa, Italy) with a multistep antinflammatory treatment protocol, based on disease severity at adm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brisca, Giacomo, Consolaro, Alessandro, Caorsi, Roberta, Pirlo, Daniela, Tuo, Giulia, Campanello, Claudia, Castagnola, Elio, Moscatelli, Andrea, Gattorno, Marco, Ravelli, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721096/ https://www.ncbi.nlm.nih.gov/pubmed/34988039 http://dx.doi.org/10.3389/fped.2021.783745

Ejemplares similares

Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
por: Mariani, Marcello, et al.
Publicado: (2022)

Cardiovascular Manifestations in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 According to Age
por: Campanello, Claudia, et al.
Publicado: (2022)

Incidence rate of MIS‐C in paediatrics: A good reason to vaccinate children against SARS‐CoV‐2
por: Castagnola, Elio, et al.
Publicado: (2021)

COVID-19 Pneumomediastinum: Possible Role of Transesophageal Echo in Bedside Percutaneous Bicaval Double-Lumen ECMO Cannulation in Children. A Case Report
por: Moscatelli, Andrea, et al.
Publicado: (2021)

Learning from the COVID-19 pandemic: IMCU as a more efficient model of pediatric critical care organization
por: Brisca, Giacomo, et al.
Publicado: (2023)

Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?
por: Matucci-Cerinic, Caterina, et al.
Publicado: (2021)

Efficacy of anakinra on rebound of multisystem inflammatory syndrome
por: Brisca, Giacomo, et al.
Publicado: (2022)

Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study
por: Licciardi, Francesco, et al.
Publicado: (2023)

Multisystem inflammatory syndrome in children (MIS-C) and “Near MIS-C”: A continuum?
por: Khafaja, Sarah, et al.
Publicado: (2023)

Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey
por: Minoia, Francesca, et al.
Publicado: (2022)

New perspectives for natural antimicrobial peptides: application as antinflammatory drugs in a murine model
por: Capparelli, Rosanna, et al.
Publicado: (2012)

Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice
por: Recinella, Lucia, et al.
Publicado: (2020)

MIS-C Treatment: Is IVIG Always Necessary?
por: Licciardi, Francesco, et al.
Publicado: (2021)

Platelet role in the prediction of MIS-C severity
por: Snipaitiene, Ausra, et al.
Publicado: (2023)

Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?
por: Licciardi, Francesco, et al.
Publicado: (2022)

New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets
por: Brullo, Chiara, et al.
Publicado: (2020)

The impact of COVID-19 lockdown on infectious diseases epidemiology: The experience of a tertiary Italian Pediatric Emergency Department
por: Rotulo, Gioacchino Andrea, et al.
Publicado: (2021)

Recognizing a MIS-Chievous Cause of Acute Viral Gastroenteritis
por: Josyabhatla, Rohit, et al.
Publicado: (2021)

COVID-19: Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Aldawas, Abdullah, et al.
Publicado: (2022)

Identification of a pediatric acute hypoxemic respiratory failure signature in peripheral blood leukocytes at 24 hours post-ICU admission with machine learning
por: Grunwell, Jocelyn R., et al.
Publicado: (2023)

MON-478 Antinflammatory and Antioxidant Effects of MIA-690 and MR-409 in GHRHKO Mice Colon and Prefrontal Cortex
por: Leone, Sheila, et al.
Publicado: (2019)

Publisher Correction: Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice
por: Recinella, Lucia, et al.
Publicado: (2020)

Editorial: Kawasaki disease: an ongoing enigma tangled with the appearance of MIS-C
por: Bratincsak, Andras, et al.
Publicado: (2023)

Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review
por: Trapani, Sandra, et al.
Publicado: (2022)

The impact of COVID-19 lockdown on children with medical complexity in pediatric emergency department
por: Brisca, Giacomo, et al.
Publicado: (2021)

Is SARS-CoV-2 Infection a Risk for Potentiation of Epileptic Seizures in Children With Pre-existing Epilepsy?
por: Brisca, Giacomo, et al.
Publicado: (2021)

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
por: Pontali, Emanuele, et al.
Publicado: (2020)

Case Report: MIS-C Temporarily Associated With COVID-19 Complicated by Reye's Syndrome
por: Pessoa, Fabrício Silva, et al.
Publicado: (2021)

HMGB1 in Pediatric COVID-19 Infection and MIS-C: A Pilot Study
por: Petrarca, Laura, et al.
Publicado: (2022)

Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
por: Çaǧlayan, Şengül, et al.
Publicado: (2022)

Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome
por: Buda, Piotr, et al.
Publicado: (2022)

Outpatient monitoring of patients with multisystem inflammatory syndrome (MIS-C): A mini review
por: Jose, Jerin Tresa, et al.
Publicado: (2022)

Acute Ischemic Stroke in a Teenage Patient: Are We “MIS-C”ing Something?
por: Moin, Aleena, et al.
Publicado: (2023)

Case Report: Simil-Appendicitis Presentation May Precede Cardiac Involvement in MIS-C Patient
por: Trevisan, Matteo, et al.
Publicado: (2022)

The prevalence and outcomes of hyponatremia in children with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)
por: Dalal, Neal, et al.
Publicado: (2023)

Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C
por: Maddux, Aline B., et al.
Publicado: (2023)

Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
por: Papa, Riccardo, et al.
Publicado: (2020)

Multisystem Inflammatory Syndrome in Children (MIS-C)—A Case Series in December 2020 in Vienna, Austria
por: Kurz, Herbert, et al.
Publicado: (2021)

Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report
por: La Torre, Francesco, et al.
Publicado: (2023)

COVID-19 mortality and ICU admission: the Italian experience
por: Immovilli, Paolo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hnc85sr039hqtpt7g4ed7b4dco